Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy
収録刊行物
-
- Supportive Care in Cancer
-
Supportive Care in Cancer 18 (9), 1171-1177, 2009-09-12
Springer Science and Business Media LLC